article

Drug Target Review – Issue #3 2015

Posted: 21 September 2015 | Drug Target Review

Included in this issue: Drug Development, Microfluidics, Proteomics, Ion Channels, GPCR, Imaging, Flow Cytometry, Enzymes

DTR Issue 3 2015

In Issue #3 2015 of Drug Target Review:

  • FOREWORD
    When 0.77% is greater than 1%: salutatory lessons from the Court of Appeal
    Jacob Gifford Head, Thomas More Chambers
  • DRUG DEVELOPMENT
    Immunogenicity: anticipating and avoiding issues for biopharmaceutical development
    Paul Chamberlain, NDA Advisory Board
  • MICROFLUIDICS
    Microfluidic technology: the next-generation drug discovery tool
    Kimberly Plevniak and Mei He, Kansas State University
  • IN-DEPTH FOCUS: PROTEOMICS
    With articles from David J. Britton and Pedro R. Cutillas, Barts Cancer Institute, and Manfred Raida, National University of Singapore
  • ION CHANNELS
    Small molecules versus biologics: the quest for the ideal Nav1.7 inhibitor
    Marzia Martina and Martin N. Perkins, National Research Council of Canada
  • GPCR
    Exploiting functional selectivity of GPCRs in drug development
    Niklas Larsson and Torben Østerlund, AstraZeneca
  • IN-DEPTH FOCUS: IMAGING
    Featuring articles from Dimitri Scholz and Jeremy C. Simpson, University College Dublin, University of Glasgow’s Rudi Marquez, plus Zuzana Flachbartova, University of Veterinary Medicine and Pharmacy. Q&A interview with Molecular Devices
  • FLOW CYTOMETRY
    Flow cytometry: not just a box in a lab
    Rachael Walker, Babraham Institute
  • ENZYMES
    Ubiquitin-specific proteases as druggable targets
    Mindy I. Davis and Anton Simeonov, National Institutes of Health

Issue #3 2015 is restricted - login or subscribe free to access

Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 


Related topics
,

Send this to a friend